HengHong Technology Inc. (HCPC)
HengHong Technology will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $6.00
Shares Offered
2,000,000
Deal Size
$10.00M
Company Description
HengHong Technology, primarily through Hainan HengCheng Health Industrial, is engaged in the business of distribution of pharmaceutical products in China.
We generate our revenue mostly from the distribution of traditional Chinese medicines and chemical medical products, and also from providing promotion and marketing services.
The Company only provides promotion and marketing services to one customer, which is also a related party.
The main products that we sell are Chinese medicines for cold, flu and cough, normally the demand is slightly higher during the flu season which is in winter and early spring.
HengHong Technology Inc.
| Country | China |
| Founded | 2008 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 115 |
| CEO | Wei Zhao |
Contact Details
Address: 3rd Floor, A-24 Building, Hainan Eco-Software Park Old town development Zone, Chengmai County, Hainan Province 571900 China | |
| Phone | + (86) 898-67488011 |
Stock Details
| Ticker Symbol | HCPC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| CIK Code | 0002050020 |
| SIC Code | 5047 |
Key Executives
| Name | Position |
|---|---|
| Weixiong Tan | Chairman of the Board and Director |
| Wei Zhao | Chief Executive Officer and Director |
| Wei Tang | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 27, 2025 | F-1 | Registration statement for certain foreign private issuers |
| Feb 18, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Dec 27, 2024 | DRS | [Cover] Draft Registration Statement |